London pre-open: Dull start for London
2nd Sep 2010 07:38
Despite the strong showing overnight by Wall Street and Asian markets London appears set for a subdued start, with City sources predicting the FTSE 100 will open down by around 16 points from yesterday's close. Global recruitment firm Hays saw a return to growth in the second half of its financial
Read moreEurope backs Astra's Seroquel XR as add-on for depression
2nd Sep 2010 07:09
AstraZeneca has received approval from the European Commission (EC) for its schizophrenia and bipolar drug Seroquel XR as an add-on treatment for major depressive episodes where antidepressants haven't worked. The drug giant will now start obtaining local approvals, which will take about 30 days in
Read moreLondon close: Footsie rallies amid US optimism
31st Aug 2010 17:00
Footsie gave up its poor start to close in the red after positive economic figures from the US. The latest survey on US consumer confidence came in ahead of expectations, easing fears over the state of the world's biggest economy. The reading on consumer confidence for August was 53.5, ahead of exp
Read moreLondon afternoon: Markets continue to struggle
31st Aug 2010 14:22
It remains a struggle for blue chips today with US markets unlikely to give much help as futures point to an early fall. Investors are now nervous about a Conference Board report on consumer confidence in the world's number one economy later today. Here, GfK NOP's consumer confidence index came in
Read moreLondon midday: Shares stuck lower
31st Aug 2010 12:04
The leading share index has failed to make any progress after its early slide, remaining firmly in the red. The fall comes after a slide in Wall Street last night. Investors are now nervous about a Conference Board report on consumer confidence in the world's number one economy later today. Here
Read moreFTSE 100 movers: TUI Travel disappointment
10th Aug 2010 13:49
Travel operator TUI Travel is the biggest faller in the Footsie after it warned profits this year will be at the low end of forecasts after poor bookings. TUI's third quarter profit of £103m was in line with expectations. Volcanic ash disruption cost £105m. Bookings by Britons are down by 2% over
Read moreLondon close: Financials lead the way
9th Aug 2010 17:05
Leading equities trod water for the afternoon session consolidating strong gains made in the morning. Hopes that the US Federal Reserve will introduce new economic stimulus measures this week played well with the financial sector, with the likes of fund managers Schroders and St. James's Place and
Read moreLondon afternoon: Gains consolidated
9th Aug 2010 14:18
Footsie hit its peak at around 10:00am and has been moving sideways ever since on a relatively quiet day for corporate news. In a buoyant insurance sector Prudential is firmer prior to Thursday's results while Aviva is lifted by Panmure Gordon raising its price target from 496p to 535p. Reboundi
Read moreLondon midday: Blue chips power ahead
9th Aug 2010 12:11
Footsie is powering forward on the back of strong performances from financials and miners. Lonmin and Kazakhmys are the best performing miners, while among financials the stand-out stocks are spread around the insurance (Legal & General, Prudential), banking (Barclays), fund management (Schroders )
Read moreLondon open: Footsie rebounds over 5,400
9th Aug 2010 08:48
A late rally in the US on Friday has helped Footsie rebound through 5,400 again. International Power is the best performer on widespread reports it will reveal a merger with French utility GDF Suez. That should trigger a £1.3bn windfall for International Power shareholders. The deal is expected to
Read moreLondon pre-open: Footsie targets 5,400
9th Aug 2010 07:32
A late rally in the US on Friday should be enough to get London back within spitting distance of 5,400. Wall Street added almost 100 points after the FTSE 100 stopped trading for the weekend. Futures prices indicate an early 59-point advance. BP's "static kill" and cementing procedures at the brok
Read moreAstraZeneca pays out $198m over Seroquel
9th Aug 2010 07:09
Drug giant AstraZeneca said it had agreed to pay a total of $198m (£124m) in compensation to about 17,500 claimants in the US in relation to its bipolar disorder treatment Seroquel. The terms of the agreements, which came after court mediation, are confidential, Astra said. Seroquel has been linked
Read moreAstraZeneca Buys 0.5M In Own Shares
2nd Aug 2010 08:43
LONDON (Dow Jones)--AstraZeneca PLC (AZN.LN), announced Monday it purchased for cancellation 500,000 ordinary shares at a price of 3253 pence per share. MAIN FACTS: -Shares at 0741 GMT up 4 pence, or 0.12%, at 3242 pence. -By Zechariah Hemans, Dow Jones Newswires; 44-20-7842-9411; zechar
Read moreMARKET TALK: CytoFab Delay Marginal For BTG -Ambrian
30th Jul 2010 09:19
0819 GMT [Dow Jones] A delay to development of BTG's (BGC.LN) experimental sepsis treatment CytoFab has only a marginal impact on BTG's valuation, says Ambrian analyst Chris Redhead. AstraZeneca (AZN.LN), which is developing CytoFab, said Thursday it expects to file the product for approval in 2015
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jul 2010 09:19
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0819 GMT [Dow Jones] A delay to development of BTG's (BGC.LN) experimental sepsis treatment CytoFab has only a marginal impa
Read more